Related Experiment Video
Updated: Apr 13, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor
M Scholz1, S Tselmin1, S Fischer1
1Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
Insights
Elevated triglycerides (hypertriglyceridemia) increase cardiovascular event risk, especially with metabolic vascular syndrome. Lipid-lowering therapy effectively reduced cardiovascular events and pancreatitis incidence in patients.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- The link between high triglycerides (HTG) and cardiovascular diseases (CVD) is debated.
- This study examines cardiovascular events (CVE) and pancreatitis in HTG patients.
Purpose of the Study:
- To analyze CVE and pancreatitis incidence in HTG patients.
- To evaluate therapeutic regimens for HTG.
- To assess the impact of HTG severity and co-existing metabolic vascular syndrome (MVS) on outcomes.
Main Methods:
- Retrospective analysis of 232 HTG patients (183 mild, 49 severe).
- Subgroup analysis by gender, MVS presence, and lipid levels.
- Evaluation of therapeutic interventions, including omega-3 fatty acids and fibrates.
Main Results:
- CVE occurred at a younger age compared to general population rates.
- TG levels, CVE, and pancreatitis rates decreased with therapy.
- Non-compliant patients with persistent severe HTG faced high pancreatitis risk.
Conclusions:
- No direct TG-CVE link found, but HTG combined with MVS is highly dangerous.
- Lipid-lowering therapy effectively reduced CVE and pancreatitis.
- Patient compliance is crucial for managing severe HTG and preventing complications.
Background:
Although a relationship between elevated triglycerides (TG) and cardiovascular diseases is generally accepted, its extent is still discussed. This retrospective study analyzed the incidence of cardiovascular events (CVE) and pancreatitis as well as the therapeutic regimen in patients being treated for hypertriglyceridemia (HTG) at an outpatient department.
Methods:
The cohort included 183 patients with mild and 49 patients with severe HTG; subgroups were formed and compared according to gender, presence of metabolic vascular syndrome (MVS) and lipid values.
Results:
Patients in this study seem to have had CVE at younger age than reported event rates in the general population. TG levels, rates of CVE and pancreatitis were reduced in all groups during therapy, which could be linked to use of omega-3 fatty acids and fibrates. Patients with persisting severe HTG as a result of incompliance showed massive risk for pancreatitis.
Conclusion:
Although no significant association between TG levels and CVE could be established, the combination of HTG and other cardiovascular risk factors such as MVS seems to be especially dangerous. The lipid-lowering drug therapy appeared to be effective with respect to CVE and pancreatitis incidence.
More Related Videos
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction
Angina IV: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...